From coal tar dyes to life-saving medicine: the evolution of the pharmaceutical industry
In short: The modern pharmaceutical industry began in the mid-1800s, born from synthetic dye manufacturers seeking new applications for their chemicals. What started as local apothecary shops evolved into a global powerhouse, fundamentally altering human health through systematic drug discovery, rigorous regulation, and the development of life-saving vaccines and treatments.
The pharmaceutical industry emerged in the late 19th century as businesses in Germany, Switzerland, and the United States began applying synthetic organic chemistry to human health. Companies like Bayer and Pfizer, which originated as local apothecary shops, leveraged the burgeoning science of pharmacology to systematically vary chemical structures and evaluate their biological effects. This era saw the transition from traditional botanical drugs, such as morphine extracted by Friedrich Sertürner in the early 1800s, to the industrial synthesis of targeted compounds.
The 20th century brought both monumental medical breakthroughs and necessary regulatory evolution. Following the 1937 Elixir Sulfanilamide tragedy, which claimed over 100 lives, the U.S. Congress passed the 1938 Federal Food, Drug, and Cosmetic Act, mandating pre-market safety testing. This period also saw the rapid development of life-saving interventions, including insulin, antibiotics like sulfonamides and penicillin, and vaccines for polio and measles. These advancements contributed to a significant acceleration in the U.S. death rate decline between 1940 and 1955.
Despite these achievements, the industry remains a subject of intense scrutiny. Critics point to issues like disease mongering, aggressive lobbying, and the high cost of essential medications. While the industry has been instrumental in managing chronic conditions—such as hypertension through drugs like chlorothiazide—it continues to navigate a complex landscape of intellectual property rights, public funding, and the ongoing challenge of balancing profit with equitable access to medicine.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Pharmaceutical industry
To cite this card, link to https://intellectplus.co.uk/app/technology-pharmaceutical-industry.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Cars · More in Technology · Latest · A–Z · All topics